Bank Tabungan Negara Persero (BBTN)
Jakarta Exchange · Indonesia · prices in IDR · close of 19 Oct 2026
Key indicators
| Last close | IDR 850.00 |
|---|---|
| 52-week range | 835.00 – 1,505.00 |
| Return, 1 month / 3 months | −27.4% / −32.5% |
| Return, 1 year / 3 years | −31.2% / −24.4% |
| Trend | Below its 200-day average |
| RSI (14) | 13 |
| Volatility (1 year) | 41.1% |
| Worst drawdown (1 year) | -43.0% |
| Average daily value traded | 16,906.69M IDR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Bank Tabungan Negara Persero, commonly called BTN, is an Indonesian state-owned bank based in Jakarta. It focuses on housing finance, providing mortgages and home ownership loans to individual customers, alongside savings accounts, time deposits and consumer credit. The bank also serves small businesses and corporate clients with lending and deposit products. Its branch network spans Indonesia, and it operates as a commercial bank under Indonesian banking regulation, with a long history tied to encouraging household saving and home ownership.
On this site Bank Tabungan Negara Persero appears as a stock on the Jakarta Exchange (Indonesia), code BBTN, with prices in Indonesian rupiah (IDR). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Bank Tabungan Negara Persero (BBTN) trades on the Jakarta Exchange in Indonesia. It last closed at IDR 850.00 on 19 October 2026.
Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 422 of 923 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 31.2% and over the last three months it fell 32.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Jakarta Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 41 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -31.1% | ||
| From 52-week high | -43.0% | ||
| Momentum | 28 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -32.5% | ||
| 6-month return | -39.3% | ||
| 12-month return, skipping the last month | -5.3% | ||
| Risk (lower is better) | 70 · Fair | Typical risk for this exchange. | |
| Volatility (1 year) | 41.1% | ||
| Worst drawdown (1 year) | -43.0% | ||
| Liquidity | 88 · Strong | Trades actively. | |
| Average daily value traded | 16,906.69M IDR | ||
| Zero-volume days | 3.3% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −17.9% |
|---|---|
| 1 month | −27.4% |
| 3 months | −32.5% |
| 6 months | −39.3% |
| 1 year | −31.2% |
| 3 years | −24.4% |
| 5 years | – |
Signals
| 50-day / 200-day average | 1,148.30 / 1,234.50 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 37.88 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Apr 2025 | IDR 53.5705 |
| 19 Mar 2024 | IDR 49.8914 |
| 29 Mar 2023 | IDR 43.3943 |
| 14 Mar 2022 | IDR 19.9343 |
| 23 Mar 2020 | IDR 1.7555 |
| 28 May 2019 | IDR 47.1117 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Jakarta Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.